Joe Durak

Micro and small-cap investor, broker and advisor. Director and Founder of Lynx Advisors.

[Joe Durak @DurakJoe]

@Kyriaco6 Enjoy buddy

[Lynx Advisors @lynxadvisors]

@JanusElectric (#ASX: $JNS) starts national electrification rollout for heavy #transport 🇦🇺
First dealer-led conversion centre launches in SA. More partners expected to join this year. Initial rollout dealer capacity ~ 250+ trucks p/yr.
#JNS #ElectricTrucks #cleanenergy

[Bhavdip Sanghavi @bhavdip143]

I’m in India right now visiting my mum 🇮🇳 And every damn time I come back here, one thing becomes clearer than ever:

Australia 🇦🇺 is a fucking gift.

To all the people living in Australia who constantly whinge, abuse the system, disrespect the country, trash the values, and still enjoy every benefit it gives you .... get some perspective or shut the fuck up.

Australia gives you:

• Safety
• Clean air & water
• Rule of law
• Freedom to build wealth
• Dignity
• Opportunity without discrimination

And yet some people wake up every day in one of the best countries on earth and act entitled like it owes them more.

I’m NOT saying India is bad....this is my blood, my roots, my family ❤️

Open your eyes. See how hard life actually is for billions of people.

Australia didn’t have to give immigrants anything.
It gave us everything.

If you live here and don’t respect it, don’t stand up for it .... you don’t deserve it.

Gratitude isn’t optional.

Respect your country.

DYOR on life.

[Joe Durak @DurakJoe]

@StoicInvestors @lynxadvisors @memphasys I reckon we will get more sales in Europe and the Middle East before too long. Now we have TGA too, I’m hopeful of getting local contracts as well

[Bhavdip Sanghavi @bhavdip143]

For anyone wanting a deep, thoughtful breakdown of the big picture on $MEM, this is one of the best write-ups I’ve seen:

👉 https://t.co/IoabSZk3oI

It captures exactly what I’ve been saying … it’s a decades-in-the-making commercial transformation, and yesterday’s news just delivered the final keys to unlock it.

TGA + CE Mark + global contracts activated + multiple regions now cleared = execution mode.

When a compelling industry narrative, clinical validation, partner pull-through demand, and real commercial rollout all line up ..... that’s when big moves begin.

Read that piece if you want a framework for why this is far bigger than most investors currently appreciate.

In the last six weeks, $MEM has secured CE Mark and TGA approvals, unlocking multiple commercial opportunities in a ~$1.5 billion annual sperm separation market.

For me?

Yesterday's TGA approval and past contract activations just further confirm the thesis ... and it’s exactly the same setup that delivered huge returns in $4DX.

DYOR.

[Lynx Advisors @lynxadvisors]

Great news for @memphasys (ASX: $MEM), securing early TGA approval for the Felix™ system - an automated IVF lab platform that selects high-quality eggs, improving consistency & potentially IVF success rates. This accelerates MEM's commercial rollout in Australia. #HealthTech

[Joe Durak @DurakJoe]

@LocantroTony Nice one Tony

[Joe Durak @DurakJoe]

https://t.co/LTcOz8zNG8

[Lynx Advisors @lynxadvisors]

Spenda Limited (ASX: $SPX) is hosting an investor webinar TODAY at 12:30 PM following Q2 FY26 results release with an update on the company's new strategy and very positive Board changes.
#ASX #SPX #InvestorWebinar #FinTech

[Joe Durak @DurakJoe]

@David_TaskerIR @memphasys Great article Dave - it totally resonates with me as I first invested in $MEM at the same time. So great to see the company delivering now!

[David Tasker @David_TaskerIR]

@memphasys $MEM enters trading halt pending key regulatory milestone - a critical step in unlocking markets & accelerating commercial rollout of Felix™.

Regulatory progress → market access → revenue.

Announcement expected shortly.

Worth watching.

#ASX #Biotech #MedTech #IVF #SmallCaps

[David Tasker @David_TaskerIR]

@memphasys (ASX: MEM) makes its first European move.

A five-year Italian IVF supply deal + an initial order placed ahead of CE Mark approval - an important signal of commercial validation for Felix™.

Read full article on @techinvestmag 👇

https://t.co/P9ruSBjetp

[Joe Durak @DurakJoe]

@Ruycorto And same to you and your family Rui. You are such a valued member of the X Fintwit community mate 👍

[Joe Durak @DurakJoe]

@Ruycorto Thanks mate - really appreciate it

[Rui @Ruycorto]

Which #ASX stock would you like me to analyze?

I’ll pick a few and post the charts over the weekend!

Like & Retweet = 100% guaranteed chart request! — make sure to rest up and recharge.🙏 🎄🧑‍🎄

[Joe Durak @DurakJoe]

@bhavdip143 momentum building nicely at $MEM

[Bhavdip Sanghavi @bhavdip143]

🔥🚀 $MEM – THIS is what real commercial traction looks like 🚀🔥

Key MENA partner ITL has placed an EARLY order for 500 Felix™ cartridges BEFORE CE Mark approval..... accelerating ahead of contractual requirements due to strong clinic-level demand.

This order was NOT required yet. It was pulled forward because IVF clinics in Qatar & UAE are already switch-ready and want inventory positioned the moment regulatory clearance lands.

Key takeaways:

✅ 500 cartridges ordered ahead of schedule

✅ Delivery requested ASAP → January 2026

✅ Clinics operationally prepared to activate Felix™ immediately on CE Mark

✅ Early demand generated via Memphasys’ direct-selling model, not distributor push

This is a massive validation of the go-direct commercial strategy.
Memphasys’ clinical team has been embedded on the ground ... training embryologists, aligning procurement teams, forecasting cartridge utilisation, and ensuring clinics are fully ready.

The result? Orders placed BEFORE approval.

Even more bullish:
💥 Management now believes the minimum contracted MENA order may be exceeded

💥 Additional orders could be brought forward

💥 Demand is coming bottom-up from clinics, giving real visibility on recurring revenue

This comes on top of:

– Multi-year exclusive MENA agreement

– India supply agreement with 200+ clinics

– Advanced deals in Japan & NZ

– CE Mark expected early 2026 = step-change event

$MEM is no longer a “story stock”.

It’s executing, contracting, and pulling forward revenue before approvals even land.

One of the most undervalued medtech / biotech names on the ASX right now.... and the market hasn’t caught up yet.

DYOR.

[Joe Durak @DurakJoe]

Well done to @SwiftNetworksAu (#ASX : $SW1) on this transformational milestone. This deal is a powerful validation of Swift’s R&D investment and commercial momentum, with Swift TV pre-orders now open and growing interest across the sector #ASXnews #smallcap #agecaretech

[Joe Durak @DurakJoe]

@thisisanfield There is no I in the word team!